Trial ID: | L5513 |
Source ID: | NCT06203275
|
Associated Drug: |
Paroxetine
|
Title: |
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
|
Acronym: |
|
Status: |
NOT_YET_RECRUITING
|
Study Results: |
NO
|
Results: |
|
Conditions: |
Diabetes Mellitus, Type 2
|
Interventions: |
DRUG: Paroxetine|DRUG: Placebo
|
Outcome Measures: |
Primary: The primary outcome is the change in glycated Hemoglobin (HbA1c)., 3 months|Change in HOMA-IR ., 3 months | Secondary: The secondary outcome is the change in expression of GRK2, 3 months
|
Sponsor/Collaborators: |
Sponsor: aya ramadan ashmawy sarhan
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
PHASE3
|
Enrollment: |
44
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
Start Date: |
2024-01
|
Completion Date: |
2026-01
|
Results First Posted: |
|
Last Update Posted: |
2024-01-12
|
Locations: |
|
URL: |
https://clinicaltrials.gov/show/NCT06203275
|